Business Description
Thermo Fisher Scientific Inc
NAICS : 541380
SIC : 3826
ISIN : ARBCOM4601F7
Share Class Description:
BUE:TMO: CedearTotal Employee Number:
125,000Compare
Compare
Traded in other countries / regions
TMO.USATMOS34.BrazilTMO.Canada0R0H.UKTN8.GermanyTMO.ArgentinaTMO.MexicoTMO.PeruTMOF.Austria1TMO.ItalyTMOCL.Chile IPO Date
2019-03-07Description
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.81 | |||||
Debt-to-EBITDA | 3.53 | |||||
Interest Coverage | 5.78 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.77 | |||||
Beneish M-Score | -2.44 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.1 | |||||
3-Year EBITDA Growth Rate | 0.1 | |||||
3-Year EPS without NRI Growth Rate | -0.5 | |||||
3-Year FCF Growth Rate | -1.7 | |||||
3-Year Book Growth Rate | 8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 9.81 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.09 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.24 | |||||
9-Day RSI | 54.75 | |||||
14-Day RSI | 56.93 | |||||
3-1 Month Momentum % | 34.26 | |||||
6-1 Month Momentum % | 32.7 | |||||
12-1 Month Momentum % | 34.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.55 | |||||
Quick Ratio | 1.18 | |||||
Cash Ratio | 0.27 | |||||
Days Inventory | 74.12 | |||||
Days Sales Outstanding | 70.99 | |||||
Days Payable | 43.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.26 | |||||
3-Year Dividend Growth Rate | 12.7 | |||||
Forward Dividend Yield % | 0.27 | |||||
5-Year Yield-on-Cost % | 0.51 | |||||
3-Year Average Share Buyback Ratio | 1.2 | |||||
Shareholder Yield % | -0.23 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.8 | |||||
Operating Margin % | 18.29 | |||||
Net Margin % | 15.04 | |||||
EBITDA Margin % | 26 | |||||
FCF Margin % | 15.85 | |||||
OCF Margin % | 19.51 | |||||
ROE % | 13.42 | |||||
ROA % | 6.44 | |||||
ROIC % | 8.29 | |||||
3-Year ROIIC % | -2.15 | |||||
ROC (Joel Greenblatt) % | 56.1 | |||||
ROCE % | 9.71 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 8 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 32.8 | |||||
Forward PE Ratio | 1.05 | |||||
PE Ratio without NRI | 25.59 | |||||
Shiller PE Ratio | 38.24 | |||||
Price-to-Owner-Earnings | 33.19 | |||||
PEG Ratio | 10.24 | |||||
PS Ratio | 4.93 | |||||
PB Ratio | 4.28 | |||||
Price-to-Free-Cash-Flow | 31.32 | |||||
Price-to-Operating-Cash-Flow | 25.42 | |||||
EV-to-EBIT | 29.01 | |||||
EV-to-Forward-EBIT | 26.45 | |||||
EV-to-EBITDA | 21.92 | |||||
EV-to-Forward-EBITDA | 20.23 | |||||
EV-to-Revenue | 5.7 | |||||
EV-to-Forward-Revenue | 5.23 | |||||
EV-to-FCF | 36.09 | |||||
Price-to-GF-Value | 1.02 | |||||
Price-to-Projected-FCF | 2.04 | |||||
Price-to-DCF (Earnings Based) | 0.06 | |||||
Price-to-DCF (FCF Based) | 0.09 | |||||
Price-to-Median-PS-Value | 1.03 | |||||
Earnings Yield (Greenblatt) % | 3.45 | |||||
FCF Yield % | 3.25 | |||||
Forward Rate of Return (Yacktman) % | 2.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Thermo Fisher Scientific Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ARS) | 65,986,988.116 | ||
| EPS (TTM) (ARS) | 26487.227 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.73 | ||
| 3-Year Sortino Ratio | 1.45 | ||
| Volatility % | 28.94 | ||
| 14-Day RSI | 56.93 | ||
| 14-Day ATR (ARS) | 819.717681 | ||
| 20-Day SMA (ARS) | 44397 | ||
| 12-1 Month Momentum % | 34.18 | ||
| 52-Week Range (ARS) | 29020 - 46300 | ||
| Shares Outstanding (Mil) | 369.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Thermo Fisher Scientific Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Thermo Fisher Scientific Inc Stock Events
| Event | Date | Price (ARS) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-26 | In 166 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-01-29 08:30 | In 139 days | ||
| Fourth quarter earnings results for 2026 | 2027-01-29 | In 138 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-22 08:30 | In 40 days | ||
| Third quarter earnings results for 2026 | 2026-10-22 | In 39 days | ||
| Morgan Stanley 24th Annual Global Healthcare Conference | 2026-09-15 09:15 | In 3 days | ||
| USD 0.021364 Cash Dividend | 2026-09-15 | In 2 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-23 08:30 | 37,560.00 (+1.29%) | ||
| Second quarter earnings results for 2026 | 2026-07-23 | 37,560.00 (+1.29%) | ||
| USD 0.021364 Cash Dividend | 2026-06-12 | 32,340.00 (-1.82%) |
Show
Entries
Thermo Fisher Scientific Inc Frequently Asked Questions
What is Thermo Fisher Scientific Inc(BUE:TMO)'s stock price today?
The current price of BUE:TMO is ARS44380.00. The 52 week high of BUE:TMO is ARS46300.00 and 52 week low is ARS29020.00.
When is next earnings date of Thermo Fisher Scientific Inc(BUE:TMO)?
The next earnings date of Thermo Fisher Scientific Inc(BUE:TMO) is 2026-10-22 Est..
Does Thermo Fisher Scientific Inc(BUE:TMO) pay dividends? If so, how much?
The Dividend Yield %  of Thermo Fisher Scientific Inc(BUE:TMO) is 0.26% (As of Today), Highest Dividend Payout Ratio of Thermo Fisher Scientific Inc(BUE:TMO) was 0.08. The lowest was 0.04. And the median was 0.06. The  Forward Dividend Yield % of Thermo Fisher Scientific Inc(BUE:TMO) is 0.27%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers